Carlos Sacanell, a 59-year-old resident of Willow Grove, Pennsylvania, has been sentenced to two years in prison and fined $5,000 for insider trading related to CVS Health Corporation’s acquisition of Oak Street Health in 2023. The sentence was handed down by United States District Judge Wendy Beetlestone, according to an announcement from U.S. Attorney David Metcalf.
Sacanell was indicted in October 2024 and pleaded guilty in September 2025 to one count of securities fraud (insider trading) and one count of making a false statement to a federal agency.
According to court documents and admissions made by Sacanell, he received confidential information about the CVS acquisition from his domestic partner, who worked as an executive at Oak Street Health. Both companies were publicly traded on the New York Stock Exchange at the time under the ticker symbols CVS and OSH.
Using this nonpublic information, Sacanell bought stock and options in Oak Street Health before the acquisition was announced on February 8, 2023. He profited approximately $617,000 from these trades.
During an interview with FBI agents in April 2024, Sacanell falsely claimed that he had not received any information about the planned acquisition from his domestic partner prior to its public announcement.
The investigation was conducted by the FBI and prosecuted by Assistant United States Attorney Francis A. Weber. The Securities and Exchange Commission also brought parallel charges against Sacanell.
